GTBPVSUROY• 6 Months (Normalized)
GTBP vs UROY (GT Biopharma Inc. vs Uranium Royalty Corp.)
Showing Closing Date Range from Apr 5 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+1270.79%
GT Biopharma Inc.
Normalized Baseline0.00%
UROY Performance $3.97
+9.37%
Uranium Royalty Corp.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1261.42 pts
GTBP outperforming by 1261.42 percentage points
GTBPUROY
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP UROY
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | GTBP Price | GTBP Gain (%) | UROY Price | UROY Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +1270.79% | $3.97 | +9.37% | +1261.42% |
| Sep 29, 2026 | $6.88 | +1444.94% | $- | - | |
| Sep 28, 2026 | $6.80 | +1428.09% | $4.00 | +10.19% | +1417.90% |
| Sep 25, 2026 | $6.89 | +1448.31% | $4.14 | +14.05% | +1434.26% |
| Sep 24, 2026 | $6.83 | +1434.83% | $4.25 | +17.08% | +1417.75% |
| Sep 23, 2026 | $7.10 | +1495.51% | $4.42 | +21.76% | +1473.75% |
| Sep 22, 2026 | $- | $4.51 | +24.24% | - | |
| Sep 21, 2026 | $7.18 | +1513.48% | $4.24 | +16.80% | +1496.68% |
| Sep 18, 2026 | $7.16 | +1508.99% | $4.56 | +25.62% | +1483.37% |
| Sep 17, 2026 | $7.49 | +1583.15% | $4.48 | +23.42% | +1559.73% |
| Sep 16, 2026 | $7.81 | +1655.06% | $4.39 | +20.94% | +1634.12% |
| Sep 15, 2026 | $9.00 | +1922.47% | $4.28 | +17.91% | +1904.56% |
| Sep 14, 2026 | $11.63 | +2513.48% | $4.24 | +16.80% | +2496.68% |
| Sep 11, 2026 | $8.61 | +1834.83% | $4.36 | +19.97% | +1814.86% |
| Sep 10, 2026 | $6.18 | +1288.76% | $4.50 | +23.97% | +1264.79% |
Page 1 of 9